The DePuy Hip Replacment Recall Can Be Partly Blamed To The FDA
Safety is a word that people use to associate with all the medical products available for the public to use. The Food and Drug Administration is the branch of our government that would make this belief true. In order to ensure the product’s quality, the FDA will see to it that the product will go through the necessary tests. Nevertheless, it must be noted that the tests will be done by the manufacturer of the product. The FDA would only do its work by determining if the product’s advantages exceed its risks.
A time can happen when a product can be available in the market without going through certain tests . The premarket notification also known as 510(k) makes this possible because the product’s quality is determined by the products already approved by the FDA that came through the same employer. Acquiring premarket notification will make a manufacturer gain a lot. This can be explained through spending less money and less time. This happens to be quite beneficial to the manufacturer but works for the public in an opposite way. The product’s failure can be a reason for this. Making the product go through necessary tests will be the only way to assure quality.
A premarket notification clearance has made to DePuy’s ASR XL Acetabular System and the ASR Hip Resurfacing System to be available in the market which happens to be defective products. FDA believed that this other product has the same quality with previously approved ones. This puts the purchasing public at a losing situation because if the product happens to be defective, they will be the one to suffer the consequences.
Suffering should not have happened on the individuals affected by the recall. These suffering have made these individuals to file a DePuy lawsuit. This situation should be better discuss with your lawyer if you happen to be one of the affected individuals. We can make FDA arranged their policies.